Searchable abstracts of presentations at key conferences in endocrinology

ea0086s1.3 | Bone cross-talk with other organs | SFEBES2022

Skeletal fragility and diabetes

Rauner Martina

The incidence of diabetes, a disease characterized by high blood glucose levels, is increasing worldwide. Besides the well-known complications of diabetes including cardiovascular disease, retinopathy, nephropathy, and neuropathy, also bone fragility has recently been recognized as a complication of diabetes. In fact, type 1 diabetes is associated with a 6-fold increase in hip fractures with a marked loss of bone mineral density, while type 2 diabetes is associated with a 1.5-...

ea0063s10.1 | Cancer drug-induced osteoporosis (Endorsed by Endocrine Connections) | ECE2019

Mechanisms of skeletal metastasis

Rauner Martina

Skeletal lesions are a frequent complication of breast and prostate cancer. At present, 60–80% of patients with breast or prostate cancer develop bone metastases, which frequently result in skeletal-related events, including pathological fractures, pain, and neurological syndromes that require surgery or radiotherapy, and reduce quality of life. Autocrine and paracrine factors modulate various aspects of bone metastasis, including tumor proliferation, epithelial-to-mesenc...

ea0081oc14.4 | Oral Communications 14: Late Breaking | ECE2022

Discovery of microRNA biomarkers in circulation and bone tissue from a type-2 diabetes mellitus rat model under different anti-osteoporotic treatments

Vazquez David Carro , Emini Lejla , Rauner Martina , Hofbauer Christine , Grillari Johannes , Eastell Richard , Hofbauer Lorenz C , Hackl Matthias

Metabolic changes in Type-2 Diabetes-Mellitus (T2DM) make patients more prone to develop osteoporosis and delayed bone healing. We hypothesize that microRNAs could be involved in the underlying mechanism and used as biomarkers in this context. To test this hypothesis, we analyzed microRNAs in samples from Zucker Diabetic Fatty (ZDF) rats, a T2DM model with reduced bone healing and bone mass. 11-week-old male ZDF and wildtype rats with a femur subcritical defect were treated wi...

ea0081rc14.2 | Rapid Communications 14: Late Breaking | ECE2022

Prevention of glucocorticoid-induced adipose dysfunction and hepatic lipid deposition through cold acclimation in aged mice

Gado Manuel , Ghane Zahra , Heinrich Annett , Wiedersich Denise , Bornstein Stefan R , Rauner Martina , Hofbauer Lorenz C , Henneicke Holger

Glucocorticoids (GC) are one of the most potent anti-inflammatory pharmacological agents. However, owing to their pleiotropic nature, their clinical effectiveness is frequently limited by their deleterious off-target effects. Frequently, metabolic abnormalities arise from GC excess involving the development of dyslipidaemia, insulin resistance and muscle atrophy as well as excessive fat accumulation in both white adipose tissue (WAT) and the liver. In addition, suppressed ther...

ea0073oc12.1 | Oral Communications 12: Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Prevention of glucocorticoid-induced adipose dysfunction through selective activation of β3-adrenergic signaling in mice

Gado Manuel , Heinrich Annett , Wiedersich Denise , Noll Monique , Bornstein Stefan R. , Rauner Martina , Hofbauer Lorenz C. , Henneicke Holger

Despite their therapeutic effectiveness, glucocorticoidsÂ’ (GC) clinical usage is frequently limited due to the deleterious metabolic effects. GC-induced obesity arises from excessive fat accumulation in white adipose tissue (WAT) as well as suppressed thermogenic capacity in brown adipose tissue (BAT). Since the sympathetic nervous system (SNS) plays a fundamental role in adipose tissue biology, we examined the interaction between GCs and SNS signaling in the adipose orga...